The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 328:471-475 February 18, 1993 Number 7
NextNext

Direct Diagnosis of Myotonic Dystrophy with a Disease-Specific DNA Marker
Peggy Shelbourne, June Davies, Jessica Buxton, Maria Anvret, Elisabeth Blennow, Maryse Bonduelle, Eric Schmedding, Ian Glass, Richard Lindenbaum, Russell Lane, Robert Williamson, and Keith Johnson

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Myotonic dystrophy is the most common inherited form of muscular dystrophy affecting adults. Its symptoms are not confined to muscle, and variability in their nature and in the patient's age at their onset can make diagnosis difficult. A specific unstable DNA sequence associated with myotonic dystrophy has recently been identified. We describe the use of a DNA probe (p5B1.4) that can detect this mutation directly, improving the accuracy and speed of diagnosis.

Methods We analyzed DNA extracted from the peripheral-blood lymphocytes of 112 unrelated patients with myotonic dystrophy and their families, using molecular genetic techniques. Southern blot analysis and amplification with the polymerase chain reaction were used to determine the extent of expansion of the unstable DNA sequence.

Results Probe p5B1.4 allowed direct identification of the myotonic dystrophy mutation in 108 of the 112 unrelated patients. In three families for whom the clinical and genetic data obtained with linked probes were ambiguous, the probe identified persons at risk for symptoms of this disorder and demonstrated that a possible sporadic case of myotonic dystrophy was familial. In one of these families the size of the unstable myotonic dystrophy-specific fragment decreased on transmission to offspring, who remained asymptomatic.

Conclusions The diagnosis of myotonic dystrophy is improved by the use of a probe that detects directly the mutation responsible for this disorder.


Source Information

From the Department of Anatomy, Charing Cross and Westminster Medical School (P.S., J.D., J.B., K.J.); the Department of Neurology, Charing Cross Hospital (Fulham) (R. Lane); and the Department of Biochemistry and Molecular Genetics, St. Mary's Hospital Medical School, Imperial College (R.W.) -- all in London; the Department of Clinical Genetics, Karolinska Hospital, Stockholm, Sweden (M.A., E.B.); the Department of Medical Genetics, Vrije Universiteit Brussel, Brussels, Belgium (M.B., E.S.); and the Department of Medical Genetics, Churchill Hospital, Oxford, United Kingdom (I.G., R. Lindenbaum). Dr. Richard Lindenbaum is deceased.

Address reprint requests to Dr. Johnson at the Department of Anatomy, Charing Cross and Westminster Medical School, Fulham Palace Rd., London W6 8RF, United Kingdom.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.